News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Filed: 2026-09-08 AccNo: 0001759425-26-000047 Size: 143 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
The Elmet Group Co. ("Elmet," the "Company," "we," or "our") (NASDAQ:ELMT), a U.S.-based provider of precision-engineered components and advanced high-energy systems, today announced that
Dynagas LNG Partners (NYSE:DLNG) reported quarterly earnings of $0.39 per share. This is a 56 percent increase over earnings of $0.25 per share from the same period last year. The company reported $41.188 million in
DA Davidson analyst Michael Baker downgrades Best Buy Co (NYSE:BBY) from Buy to Neutral and maintains the price target from $95 to $95.
Markel Group Inc. (NYSE:MKL) today announced that Steve Markel, Chairman of the Board of Directors, informed the Board on Thursday, September 3, 2026 that after more than 50 years of distinguished service to Markel, he
Surrozen, Inc. (Surrozen or the Company) (NASDAQ:SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening
XRP futures volume hits a six-month high of $64.6B as Ali Martinez flags a decade-long pattern targeting $60 above $3.66.
Needham analyst Ryan MacDonald reiterates ODDITY Tech (NASDAQ:ODD) from Hold to Hold.
Filed: 2026-09-08 AccNo: 0001096343-26-000074 Size: 195 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Novo Nordisk Phase 3 STEP Young trial shows once-weekly semaglutide reduced BMI in 40.4% of children with obesity after 68 weeks.
Filed: 2026-09-08 AccNo: 0001213900-26-097860 Size: 1 MB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Can Fite Biofarma (AMEX:CANF) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(1.43) by 13.29 percent. This is a 71.1 percent increase over losses of $(4.29) per share from
Filed: 2026-09-08 AccNo: 0001635282-26-000062 Size: 183 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
https://www.reuters.com/business/energy/kazakhstan-suspends-proceedings-recover-5-bln-ncoc-oil-consortium-ifx-reports-2026-09-08/
https://www.bloomberg.com/news/articles/2026-09-08/xerox-shareholder-pushes-for-activist-changes-at-company
Roth Capital analyst Jamie Clark initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutral rating and announces Price Target of $67.
Filed: 2026-09-08 AccNo: 0000798941-26-000034 Size: 786 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Oceaneering International (NYSE:OII) sees preliminary FY2026 sales of $2.800 billion-$3.000 billion vs $2.909 billion analyst estimate.
BMO Capital analyst David Lebowitz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $61 to $54.
Rothschild & Co analyst Jamie Clark initiates coverage on Natera (NASDAQ:NTRA) with a Buy rating and announces Price Target of $385.
BMO Capital analyst James Thalacker maintains CMS Energy (NYSE:CMS) with a Outperform and lowers the price target from $82 to $77.
JP Morgan analyst Arun Jayaram upgrades Magnolia Oil & Gas (NYSE:MGY) from Neutral to Overweight and raises the price target from $32 to $33.